XML 55 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2012
FAIR VALUE MEASUREMENTS  
Schedule of cash equivalents, restricted cash and marketable securities by security type

 Cash equivalents, restricted cash and marketable securities by security type at December 31, 2012 were as follows:

 
  Cost   Gross
Unrealized
Gains
  Gross
Unrealized
Losses
  Estimated
Fair Value
 
 
  (In thousands)
 

Included in cash and cash equivalents:

                         

Money market funds

  $ 15,660   $   $   $ 15,660  

Corporate notes

    3,136         (1 )   3,135  
                   

 

  $ 18,796   $   $ (1 ) $ 18,795  
                   

Restricted cash:

                         

Certificates of deposit

  $ 794   $   $   $ 794  
                   

Marketable securities:

                         

Government-sponsored enterprise securities (due in less than 1 year)

  $ 8,618   $ 5   $   $ 8,623  

Commercial paper (due in less than 1 year)

    20,623     21         20,644  

Corporate notes (due in less than 1 year)

    44,190     22     (7 )   44,205  
                   

 

  $ 73,431   $ 48   $ (7 ) $ 73,472  
                   

        Cash equivalents, restricted cash and marketable securities by security type at December 31, 2011 were as follows:

 
  Cost   Gross
Unrealized
Gains
  Gross
Unrealized
Losses
  Estimated
Fair Value
 
 
  (In thousands)
 

Included in cash and cash equivalents:

                         

Money market funds

  $ 12,885   $   $   $ 12,885  
                   

Restricted cash:

                         

Certificates of deposit

  $ 793   $   $   $ 793  
                   

Marketable securities:

                         

Certificate of deposit (due in less than 1 year)

  $ 329   $   $   $ 329  

Government-sponsored enterprise securities (due in less than 1 year)

    15,061     25     (1 )   15,085  

Government-sponsored enterprise securities (due in 1 to 2 years)

    6,998     18     (12 )   7,004  

Commercial paper (due in less than 1 year)

    39,206     41         39,247  

Corporate notes (due in less than 1 year)

    50,556     19     (28 )   50,547  

Corporate notes (due in 1 to 2 years)

    25,113     30     (14 )   25,129  
                   

 

  $ 137,263   $ 133   $ (55 ) $ 137,341  
                   
Schedule of marketable securities with unrealized losses

 

 

 
  Less Than 12 Months   12 Months or Greater   Total  
 
  Estimated
Fair Value
  Gross
Unrealized
Losses
  Estimated
Fair Value
  Gross
Unrealized
Losses
  Estimated
Fair Value
  Gross
Unrealized
Losses
 
 
  (In thousands)
 

As of December 31, 2012:

                                     

Corporate notes (due in less than 1 year)

  $ 27,045   $ (8 ) $   $   $ 27,045   $ (8 )
                           

As of December 31, 2011:

                                     

Government-sponsored enterprise securities (due in less than 1 year)

  $ 5,021   $ (1 ) $   $   $ 5,021   $ (1 )

Government-sponsored enterprise securities (due in 1 to 2 years)

    3,988     (12 )           3,988     (12 )

Corporate notes (due in less than 1 year)

    33,847     (28 )           33,847     (28 )

Corporate notes (due in 1 to 2 years)

    13,096     (14 )           13,096     (14 )
                           

 

  $ 55,952   $ (55 ) $   $   $ 55,952   $ (55 )
                           
Schedule of non-employee options to purchase common stock considered as derivatives and classified as current liabilities

 

 

 
   
  Number of Shares at
December 31,
   
   
  Fair Value at
December 31,
 
 
  Exercise
Price
  Exercisable
Date
  Expiration
Date
 
Issuance Date
  2012   2011   2012   2011  
 
   
   
   
   
   
  (In thousands)
 

March 2005

  $ 6.39     284,600     284,600   January 2007   March 2015   $ 51   $ 64  
                                     
Schedule of assumptions used to estimate the fair value of derivatives

 

 

 
  December 31,
 
  2012   2011

Dividend yield

  None   None

Expected volatility

  0.828   0.714

Risk-free interest rate

  0.25%   0.36%

Expected term

  2 yrs   3 yrs
Schedule of financial instruments measured at fair value on recurring basis

 

 

 
  Fair Value Measurements at Reporting Date Using  
 
  Quoted Prices in
Active Markets for
Identical Assets/
Liabilities
  Significant
Other
Observable
Inputs
  Significant
Unobservable
Inputs
   
 
(In thousands)
  Level 1   Level 2   Level 3   Total  

Assets

                         

Money market funds(1)

  $ 15,660   $   $   $ 15,660  

Government-sponsored enterprise securities(2)

        8,623         8,623  

Commercial paper(2)

        20,644         20,644  

Corporate notes(1)(2)

        47,340         47,340  
                   

Total

  $ 15,660   $ 76,607   $   $ 92,267  
                   

Liabilities

                         

Derivatives(3)

  $   $   $ 51   $ 51  
                   

(1)
Included in cash and cash equivalents on our consolidated balance sheet.
(2)
Included in current marketable securities on our consolidated balance sheet.

(3)
Included in fair value of derivatives on our consolidated balance sheet.
Schedule of rollforward of the balance sheet amounts for financial instruments in Level 3 category

 

 

 
  Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Year Ended December 31, 2012
 
(In thousands)
  Fair Value at
December 31,
2011
  Total
Unrealized
Gain
Included in
Earnings, net(1)
  Purchases,
Sales,
Issuances,
Settlements,
net
  Transfers
In and/or
Out of
Level 3
  Fair Value at
December 31,
2012
  Change in
Unrealized Gain
Related to
Financial
Instruments
Held at
December 31, 2012(1)
 

Derivative liabilities

  $ 64   $ (13 ) $   $   $ 51   $ (13 )

(1)
Reported as unrealized gain on derivatives in our consolidated statements of operations.